• 不 限
  • 期刊论文
  • 硕博论文
  • 会议论文
  • 报 纸
  • 英文论文
  2. 您的位置
  3. 首页
  4. 会议论文
  5. FISH+CD34+CD38-cells detected in newly diagnosed acute myeloid leukemia patients can predict the cli

FISH+CD34+CD38-cells detected in newly diagnosed acute myeloid leukemia patients can predict the cli

来源 :The 35th World Congress of the International Society of Hema | 被引量 : 0次 | 上传用户：mc_2000
【摘 要】
：
Background In acute myeloid leukemia (AML),the leukemia initiating cells (LICs) or leukemia stem cells (LSCs) is found within the CD34+CD38- cell compartment.The LICs subpopulation survives chemothera
【作 者】
：
Libing Wang Lei Gao Sheng Xu Shenglan Gong Li Chen Shuqing Lv Jie Chen Huiying Qiu Xiaoqian Xu Xiong Ni Xianmin Song Weiping Zhang Jianmin Yang Min Liu Xiaoxia Hu Jianmin Wang 
【机 构】
：
Changhai Hospital,Second Military Medical University
【出 处】
：
The 35th World Congress of the International Society of Hema
【发表日期】
：
2014年5期
下载到本地 , 更方便阅读
下载此文 赞助VIP
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
Background In acute myeloid leukemia (AML),the leukemia initiating cells (LICs) or leukemia stem cells (LSCs) is found within the CD34+CD38- cell compartment.The LICs subpopulation survives chemotherapy and is most probable the cause of minimal residual disease (MRD),which in turn is thought to cause relapse.The aim of this study was to determine the prognostic value of the percentage of LICs in blasts at diagnosis.
其他文献
c(RGDfV),AMD3100 and G-CSF disrupt the cross-talk between leukemic cells with the endosteal niche an
Background Stromal cell derived factor-1(SDF-1) and osteopontin (OPN),excreted by bone marrow osteoblasts,may be involved in shielding of endosteal niche from leukemia cells by binding to its receptor
会议
CEBPA gene mutations in Chinese patients with intermediate cytogenetic risk profile acute myeloid le
Objective To investigate CCAAT/enhancer binding protein alpha (CEBPA) gene mutations in acute myeloid leukemia (AML) patients with intermediate-risk cytogenetics.Methods Mutation analysis of the entir
会议
The Expression level of HLS5 is correlated with the Clinical Outcomes of acute lymphoid leukemia (AL
Background HLS5 belongs to the RBCC (Ring-finger,B-box,coiled-coil) family,a family of tumor suppressive genes including Pm,Tif1-α,Herf and Rfp,it has been reported to regulate erythroid differentiati
会议
ROLE OF INDUCTION AND CONSOLIDATION CHEMOTHERAPY IN ELDERLY ACUTE MYELOID LEUKEMIA
Background Diagnosis of acute myeloid leukemia (AML) at an elderly age generally predicts poor clinical outcomes.Elderly acute myeloid leukemia (AML) patients usually have a bad prognosis.Because the
会议
Immunophenotype of NK cells in patients from Mexican patients with acute myeloid leukemia. Prelimina
Introduction Natural killer (NK) cells are an important part of the organisms innate immune system.They can destroy virally infected and malignant cells without prior sensitization.These cells recogni
会议
Standard induction followed by low dose cytarabine for the treatment of acute myeloid leukemia of Do
Objective Although acute myeloid leukemia occurring in patients with Down syndrome (AML-DS)is generally chemosensitive,those patients are more susceptible to regimen-related toxicities,and the optimal
会议
SNP analyses in cytarabine metabolizing enzymes in AML patients and their impact on treatment respon
Objective Cytosine arabinoside (Ara-C) is widely used to treat acute myeloid leukemia (AML) and Ara-C metabolizing enzymes could affect the cytotoxicity of Ara-C.To assess the pharmacogenomic effects
会议
The clinical efficacy of the patients of acute myeloid leukemia and myelodysplastic syndromes treate
Objective To observe the clinical safety and efficacy of decitabine in patients of acute myeloid leukemia and myelodysplastic syndromes.Methods Totally 79 patients with MDS/AML were divided into three
会议
Study of the methylation level in vivo of the patients of myelodysplastic syndrome and acute myeloid
Objective To detect the level of MDS / AML patients treated with decitabine and study the relationship between the level of DNA methylation in the tumor cells of MDS / AML and decitabine.To discuss th
会议
High Prognostic Value of Minimal Residual Disease Detected by Flow Cytometry-Enhanced Fluorescence i
Background Acute myeloid leukemia (AML) is generally regarded as a disorder of stem cells,known as leukemic initiating cells (LICs),which initiate the disease and contribute to relapses.Although the p
会议